Patents Assigned to American Health Foundation
  • Publication number: 20030096863
    Abstract: A method is provided for inhibiting the development of colon tumorigenesis in a mammal by administering to the mammal a pharmacologically effective amount of an isothiocyanate selected from the group consisting of sulforaphane and phenethyl isothiocyanate.
    Type: Application
    Filed: July 15, 2002
    Publication date: May 22, 2003
    Applicant: AMERICAN HEALTH FOUNDATION
    Inventors: Fung-Lung Chung, Bandaru Reddy, C. Clifford Conaway
  • Patent number: 6433011
    Abstract: A method is provided for inhibiting the development of colon tumorigenesis in a mammal by administering to the mammal a pharmacologically effective amount of an isothiocyanate selected from the group consisting of sulforaphane and phenethyl isothiocyanate.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: August 13, 2002
    Assignee: American Health Foundation
    Inventors: Fung-Lung Chung, Bandaru Reddy, C. Clifford Conaway
  • Patent number: 5741678
    Abstract: There is disclosed a quantitative sensitive method to enable the detection of point mutations at a known site to a diagnostic kit which uses a multi step (for example, four steps) or a single step reaction. The method uses selective polymerase chain reaction (PCR) amplification of mutant test gene sequences involving first stage amplification of both mutant and wild-type sequences, first stage restriction enzyme digestion of only wild-type sequences, second stage amplification of undigested amplified fragments enriched in mutant sequences and second stage digestion of previously undigested wild-type sequences. Long and short tail primers are used in the first and second stages of amplification respectively to enable selective amplification (in the second stage) of only previously amplified material and none of the original test genomic DNA.
    Type: Grant
    Filed: July 23, 1996
    Date of Patent: April 21, 1998
    Assignee: American Health Foundation
    Inventor: Zeev A. Ronai
  • Patent number: 5626738
    Abstract: A method for detecting a nitrosothiol in an eluant from a chromatographic process including passing the eluant through a series of electrodes comprising an upstream working electrode and a downstream working electrode. The upstream working electrode is maintained at a potential adequate to reduce the nitrosothiol to a corresponding thiol. The downstream electrode is maintained at a potential to detect the corresponding thiol.
    Type: Grant
    Filed: November 17, 1995
    Date of Patent: May 6, 1997
    Assignee: American Health Foundation
    Inventor: John P. Richie
  • Patent number: 5512441
    Abstract: There is disclosed a quantitative sensitive method to enable the detection of point mutations at a known site to a diagnostic kit which uses a multi step (for example, four steps) or a single step reaction. The method uses selective polymerase chain reaction (PCR) amplification of mutant test gene sequences involving first stage amplification of both mutant and wild-type sequences, first stage restriction enzyme digestion of only wild-type sequences, second stage amplification of undigested amplified fragments enriched in mutant sequences and second stage digestion of previously undigested wild-type sequences. Long and short tail primers are used in the first and second stages of amplification respectively to enable selective amplification (in the second stage) of only previously amplified material and none of the original test genomic DNA.
    Type: Grant
    Filed: November 15, 1994
    Date of Patent: April 30, 1996
    Assignee: American Health Foundation
    Inventor: Zeey A. Ronai
  • Patent number: 5391568
    Abstract: A method is provided for reducing the incidence of lung cancer in a mammal by administering thereto a pharmacologically effective amount of epigallocatechin gallate (EGCG). The EGCG may be administered to the mammal in the form of drinking water and particularly in the form of, for example, 2% green tea. The EGCG may be isolated prior to administering the same and is subsequently put into solution for administration thereof. The EGCG is an antioxidant.
    Type: Grant
    Filed: July 10, 1992
    Date of Patent: February 21, 1995
    Assignee: American Health Foundation
    Inventor: Fung L. Chung
  • Patent number: 5260283
    Abstract: Wheat bran fiber is used to alter the enterohepatic recirculation of estrogens leading to an increased fecal excretion of estrogens together with a decrease in urinary excretion of estrogens. Increased lipid excretion is also found. Thus wheat bran fiber is useful to remove estrogen and lipid in mammals.
    Type: Grant
    Filed: May 19, 1992
    Date of Patent: November 9, 1993
    Assignee: American Health Foundation
    Inventors: Marcia E. Kendall, Leonard A. Cohen
  • Patent number: 5231209
    Abstract: A method of inhibiting lung tumor multiplicity and/or incidence by treating mammals with relatively long chain arylalkyl isothiocyanates, especially effective with respect to tumors induced by exposure to tobacco-specific nitrosamine. Among the isothiocyanates are 4-phenylbutyl isothiocyanate, phenylpentyl isothiocyanate and phenylhexyl isothiocyanate, which are synthesized by adding hydrochloride of phenylbutylamine, phenylpentylamine, or phenylhexylamine in water to thiophosgene in an inert organic solvent. For comparison testing, oxo-pyridyl butyl isothiocyanate is synthesized by dissolving myosmine in HCl to obtain a hydrochloride salt, suspending the salt in dry chloroform, adding thiophosgene, and adding chloroform containing triethylamine.
    Type: Grant
    Filed: December 13, 1991
    Date of Patent: July 27, 1993
    Assignee: American Health Foundation
    Inventors: Fung-Lung Chung, Stephen S. Hecht, Karin Eklind, Mark A. Morse
  • Patent number: 5114969
    Abstract: A method of inhibiting lung tumor multiplicity and/or incidence by treating mammals with relatively long chain arylalkyl isothiocyanates, especially effective with respect to tumors induced by exposure to tobacco-specific nitrosamine. Among the isothiocyanates are 4-phenylbutyl isothiocyanate, phenylpentyl isothiocyanate and phenylhexyl isothiocyanate, which are synthesized by adding hydrochloride of phenylbutylamine, phenylpentylamine, or phenylhexylamine in water to thiophosgene in an inert organic solvent. For comparison testing, oxo-pyridyl butyl isothiocyanate is synthesized by dissolving myosmine in HCl to obtain a hydrochloride salt, suspending the salt in dry chloroform, adding thiophosgene, and adding chloroform containing triethylamine.
    Type: Grant
    Filed: May 31, 1990
    Date of Patent: May 19, 1992
    Assignee: American Health Foundation
    Inventors: Fung-Lung Chung, Stephen S. Hecht, Karin Eklind, Mark A. Morse
  • Patent number: 5011697
    Abstract: L-Tryptophan is applied to foodstuff to prevent the development of mutagens/carcinogens. Before the cooking of a foodstuff such as hamburger, L-Tryptophan is applied to the surfaces thereof to inhibit, for example, the generation of IQ type carcinogens. The L-Tryptophan can be sprinkled on the surface of the foodstuff or incorporated into a sauce which is applied to the foodstuff or put into solution in water or the like.Other non-toxic indoles such as L-proline have identical properties in specifically blocking the formation of heterocyclic amino type mutagens and carcinogens, as do mixtures of L-tryptophan and L-proline.
    Type: Grant
    Filed: August 6, 1988
    Date of Patent: April 30, 1991
    Assignee: American Health Foundation
    Inventors: Ronald C. Jones, John H. Weisburger
  • Patent number: 4988517
    Abstract: It is shown that benzylselenocyanate in the diet significantly inhibits the incidence (percentage of animals with tumors) and multiplicity (number of tumors per animal) of adenocarcinomas in the colon and multiplicity of adenocarcinomas in the small intestine compared to those fed a control diet. Selenium-dependant glutathione peroxidase activity is significantly increased in kidneys and colon and small intestinal mucosae of animals fed a benzylselenocyanate diet compared to animals fed control diets. BSC in the diet is a superior inhibitor to both its sulfur analog BTC and the inorganic selenium (sodium selenite) during the initiation phase of carcinogenesis.
    Type: Grant
    Filed: September 27, 1988
    Date of Patent: January 29, 1991
    Assignee: American Health Foundation
    Inventors: Karam El-Bayoumy, Bandaru S. Reddy
  • Patent number: 4923813
    Abstract: Monoclonal antibodies specific for the 8R,6R- and 8S,6S-stereoisomers of 3-(2-deoxy-.beta.-D-erythropentofuransyl)-5,6,7,8-tetrahydro-8-hydroxy-6-m ethylpyrimido[1,2-a]purine-10(3H)one were produced. These cyclic 1,N.sup.2 -propanodeoxyguanosines are formed in DNA exposed to crotonaldehyde in vitro. Three of the four antibodies were most specific for one stereoisomer while the fourth was most specific for the other stereoisomer. Fifty % inhibition of binding in an enzyme-linked immunoabsorbent assay could be achieved with 0.2 picomol of either stereoisomer. A high-pressure liquid chromatography-enzyme-linked immunoabsorbent assay using two of these antibodies and capable of detecting 0.5 .mu.mol of 1,N.sup.2 -propanodeoxyguanosine per mol of deoxyguanosine was developed. The method was validated by comparison to results obtained with fluorescence assay.
    Type: Grant
    Filed: January 15, 1988
    Date of Patent: May 8, 1990
    Assignee: American Health Foundation
    Inventors: Stephen S. Hecht, Peter G. Foiles, Fung-Lung Chung
  • Patent number: 4777052
    Abstract: L-Tryptophan is applied to foodstuff to prevent the development of mutagens/carcinogens. Before the cooking of a foodstuff such as hamburger, L-Tryptophan is applied to the surfaces thereof to inhibit, for example, the generation of IQ type carcinogens. The L-Tryptophan can be sprinkled on the surface of the foodstuff or incorporated into a sauce which is applied to the foodstuff or put into solution in water or the like.
    Type: Grant
    Filed: January 6, 1987
    Date of Patent: October 11, 1988
    Assignee: American Health Foundation
    Inventors: John Weisburger, Ronald C. Jones